View Entire Collection
By Clinical Topic
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
TUESDAY, Feb. 21 (HealthDay News) -- Medtronic's Resolute Integrity Drug-Eluting Stent (DES) has been approved by the U.S. Food and Drug Administration for people with coronary artery disease (CAD), the Minneapolis-based company said in a news release.
A stent is a hollow mesh tube used to prop open a narrowed coronary vessel. Medtronic's Resolute Integrity DES is made from a drug-coated polymer material and resembles a flexible spring.
The device performed strongly in clinical studies, including among people with diabetes, a common contributor to CAD, Medtronic said.
CAD is the leading cause of death in the United States, killing almost 500,000 people annually, the company said.
Medline Plus has more about coronary artery disease.
Find in-depth content on major issues provided by leading companies in partnership with NursingCenter.com
BD Safety Beyond Needlestick Prevention Learning Center
Sponsored by BD Medical
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top